These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22209839)

  • 1. Distinctive microRNA signature is associated with the diagnosis and prognosis of acute leukemia.
    Zhu YD; Wang L; Sun C; Fan L; Zhu DX; Fang C; Wang YH; Zou ZJ; Zhang SJ; Li JY; Xu W
    Med Oncol; 2012 Dec; 29(4):2323-31. PubMed ID: 22209839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deregulation of miR-1, miR486, and let-7a in cytogenetically normal acute myeloid leukemia: association with NPM1 and FLT3 mutation and clinical characteristics.
    Seyyedi SS; Soleimani M; Yaghmaie M; Ajami M; Ajami M; Pourbeyranvand S; Alimoghaddam K; Akrami SM
    Tumour Biol; 2016 Apr; 37(4):4841-7. PubMed ID: 26526573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Flt-3/ITD mutation in pediatric leukemia and its clinical significance].
    Wang J; Wang T; Li S; Lin L; Gang Y
    Ai Zheng; 2007 Jan; 26(1):58-63. PubMed ID: 17222369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression characteristics and prognosis significance of miRNA-181a in acute myeloid leukemia with normal karyotype].
    Zhuang XX; Ma QL; Wang HP; Yu MX; Li X; Meng HT; Yu WJ; Jin CJ; You LS; Jin J
    Zhonghua Xue Ye Xue Za Zhi; 2017 Oct; 38(10):858-862. PubMed ID: 29166738
    [No Abstract]   [Full Text] [Related]  

  • 5. MicroRNAs expression signatures are associated with lineage and survival in acute leukemias.
    Wang Y; Li Z; He C; Wang D; Yuan X; Chen J; Jin J
    Blood Cells Mol Dis; 2010 Mar; 44(3):191-7. PubMed ID: 20110180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk assessment in patients with acute myeloid leukemia and a normal karyotype.
    Bienz M; Ludwig M; Leibundgut EO; Mueller BU; Ratschiller D; Solenthaler M; Fey MF; Pabst T
    Clin Cancer Res; 2005 Feb; 11(4):1416-24. PubMed ID: 15746041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of FLT3 gene in acute myeloid leukemia with normal cytogenetics and its association with clinical and immunophenotypic features.
    Chauhan PS; Bhushan B; Mishra AK; Singh LC; Saluja S; Verma S; Gupta DK; Mittal V; Chaudhry S; Kapur S
    Med Oncol; 2011 Jun; 28(2):544-51. PubMed ID: 20354824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High WT1 mRNA expression after induction chemotherapy and FLT3-ITD have prognostic impact in pediatric acute myeloid leukemia: a study of the Japanese Childhood AML Cooperative Study Group.
    Shimada A; Taki T; Koga D; Tabuchi K; Tawa A; Hanada R; Tsuchida M; Horibe K; Tsukimoto I; Adachi S; Kojima S; Hayashi Y
    Int J Hematol; 2012 Oct; 96(4):469-76. PubMed ID: 22915059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
    Schwind S; Maharry K; Radmacher MD; Mrózek K; Holland KB; Margeson D; Whitman SP; Hickey C; Becker H; Metzeler KH; Paschka P; Baldus CD; Liu S; Garzon R; Powell BL; Kolitz JE; Carroll AJ; Caligiuri MA; Larson RA; Marcucci G; Bloomfield CD
    J Clin Oncol; 2010 Dec; 28(36):5257-64. PubMed ID: 21079133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin.
    Garzon R; Garofalo M; Martelli MP; Briesewitz R; Wang L; Fernandez-Cymering C; Volinia S; Liu CG; Schnittger S; Haferlach T; Liso A; Diverio D; Mancini M; Meloni G; Foa R; Martelli MF; Mecucci C; Croce CM; Falini B
    Proc Natl Acad Sci U S A; 2008 Mar; 105(10):3945-50. PubMed ID: 18308931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence and clinical significance of FLT3 internal tandem duplication mutation in acute leukemia].
    Wang LH; Zhou CL; Zhang XW; Chen S; Wang M; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):393-6. PubMed ID: 15355689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-155 regulative network in FLT3 mutated acute myeloid leukemia.
    Salemi D; Cammarata G; Agueli C; Augugliaro L; Corrado C; Bica MG; Raimondo S; Marfia A; Randazzo V; Dragotto P; Di Raimondo F; Alessandro R; Fabbiano F; Santoro A
    Leuk Res; 2015 Aug; 39(8):883-96. PubMed ID: 26055960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-155 expression and correlation with clinical outcome in pediatric AML: A report from Children's Oncology Group.
    Ramamurthy R; Hughes M; Morris V; Bolouri H; Gerbing RB; Wang YC; Loken MR; Raimondi SC; Hirsch BA; Gamis AS; Oehler VG; Alonzo TA; Meshinchi S
    Pediatr Blood Cancer; 2016 Dec; 63(12):2096-2103. PubMed ID: 27511899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the key genes and microRNAs in adult acute myeloid leukemia with FLT3 mutation by bioinformatics analysis.
    Chen S; Chen Y; Zhu Z; Tan H; Lu J; Qin P; Xu L
    Int J Med Sci; 2020; 17(9):1269-1280. PubMed ID: 32547322
    [No Abstract]   [Full Text] [Related]  

  • 15. A 4-microRNA signature for survival prognosis in pediatric and adolescent acute myeloid leukemia.
    Zhu R; Lin W; Zhao W; Fan F; Tang L; Hu Y
    J Cell Biochem; 2019 Mar; 120(3):3958-3968. PubMed ID: 30242879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FLT3-ITD and CD135 Over-Expression are Frequent Findings of Poor Survival in Adult Patients with Acute Leukemias.
    Vela-Ojeda J; Cardenas PV; Garcia-Ruiz Esparza MA; Montiel Cervantes LA; Chavez JG; Caballero AH; Majluf-Cruz A; Vega-López A; Reyes-Maldonado E
    Arch Med Res; 2021 Feb; 52(2):217-223. PubMed ID: 33109387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of specific microRNA and their targets in acute myeloid leukemia.
    Cammarata G; Augugliaro L; Salemi D; Agueli C; La Rosa M; Dagnino L; Civiletto G; Messana F; Marfia A; Bica MG; Cascio L; Floridia PM; Mineo AM; Russo M; Fabbiano F; Santoro A
    Am J Hematol; 2010 May; 85(5):331-9. PubMed ID: 20425795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection and clinical significance of FLT3-ITD gene mutation in patients with acute myeloid leukemia].
    Xu YY; Gao L; Ding Y; Sun JZ; Wang N; Wang LL; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1312-5. PubMed ID: 23257423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [FMS-like tyrosine kinase 3 gene mutations in acute myeloid leukemia].
    Han YL; Zhang SJ; Qiao C; Dai D; Sun XM; Xu YL; Qian SX; Xu W; Wang JS; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1135-9. PubMed ID: 19840437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCRP mRNA and FLT3-ITD are independent poor risk factors in adult patients with acute myeloid leukemia and intermediate or normal karyotype.
    Nasiłowska-Adamska B; Warzocha K; Solarska I; Borg K; Pieńkowska-Grela B; Czyż A
    Eur J Haematol; 2017 Sep; 99(3):255-261. PubMed ID: 28618074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.